Larvol Delta - ALS-Pharma-announces-positive-topline-results-from-Phase-2-study-of-AP101-for-the-treatment-of-amyotrophic-lateral-sclerosis-ALS

AP-101 - AL-S Pharma

https://www.prnewswire.com/news-releases/al-s-pharma-announces-positive-topline-results-from-phase-2-study-of-ap-101-for-the-treatment-of-amyotrophic-lateral-sclerosis-als-302545686.html

Sep 5, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next